Possibility of pharmacological prophylaxis against highly toxic organophosphates

Chemicke Listy

Volumn 101, Issue 14, 2007, Pages

  Bajgar, Jiří ^a   Fusek, Josef ^a   Jun, Daniel ^a   Kuča, Kamil ^a   Bartošová, Lucie ^a  

^a UNIVERSITY OF DEFENCE   (Czech Republic)

Author keywords

Acetylcholinesterase inhibition; Detoxification; Neve agents; Prophylaxis; Protection

Indexed keywords

EID: 38349156393     PISSN: 00092770     EISSN: 12137103     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (35)

1. Jeyaratnam J.: World Health Stat. Q. 43, 139 (1990).
2. Bajgar J.: Adv. Clin. Chem,38, 151 (2004).
3. Eyer P.: Toxicol. Rev. 22, 165 (2003).
4. Bajgar J.: J. Med. Chem. Def. 1, 1 (2003).
5. Bajgar J., Fusek, J., Vachek J.: ASA Newsletter 94-4, 10 (1994).
6. Kassa J., Vachek J., Bajgar J., Fusek J.: Voj. Zdrav. Listy 70, Suppl., 22 (2001).
7. Fusek J., Bajgar J., Vachek J.: The prophylactic antidote against nerve paralytic agents - PANPAL. The Meeting of NATO TG 004 Task Group on Prophylaxis and Therapy of Chemical Agents, 11-13 September 2000, The Hague, The Netherlands. Abstracts p. 15. Hague 2000.
8. Kim Y. B., Cheon K. C., Hur G. H., Phi T. S., Choi S. J., Hong D., Kang J. K.: Env. Toxicol. Pharmacol. 11, 15 (2002).
9. Tuovinen K., Hanninen O.: Toxicology 139, 233 (1999).
10. Walter K., Muller M., Barkworth M. F., Niciecki A. V., Stanislaus F.: Brit. J. Clin. Pharmacol. 39, 59 (1995).
11. Lallement G., Baille V., Baubichon D., Carpentier P., Collombet J. M., Filliat P., Foquin A., Four E., Masqueliez C., Testylier G., Tonduli L., Dorandeu F.: Neurotoxicology 23, 1 (2002).
12. Grunwald J., Raveh L., Doctor B. P. Ashani Y.: Life Sci. 54, 991 (1994).
13. Wolfe A. D., Rush R. S., Doctor B. P., Koplovitz I., Jones D.: Fund. Appl. Toxicol. 9, 266 (1987).
14. Dunn M. A., Sidell F. R.: JAMA 262, 649 (1989).
15. Li W. F., Furlong C. E., Costa L. G.: Toxicol. Lett. 76, 219 (1995).
16. Raveh L., Segall Y., Leader H., Rothschild N., Levanon D., Henis Y., Ashani Y.: Biochem. Pharmacol. 44, 397 (1992).
17. Doctor B. P., Maxwell D. M., Saxena A.: Preparation and characterization of bioscavengers for possible use against organophosphate toxicity. Mini-CB Medical Treatment Symposium, 26-30 May 1997, Hradec Kralove, Czech Republic. Abstracts p. 17, Hradec Králové 1997.
18. Doctor B. P., Raveh L., Wolfe A. D., Maxwell D. M., Ashani Y.: Neurosci. Behav. Rev. 15, 123 (1991).
19. Saxena A., Maxwell D. M., Quinn D. M., Radic Z., Taylor P., Doctor B. P.: Biochem. Pharmacol. 54, 269 (1997).
20. Saxena A., Doctor B. P., Sun W., Luo C., Bansal R., Naik R. S., Fedorko J. M., Koplovitz I., Maxwell D. M., Lenz D. E., Ross M. C.: US Army Med. Dept J. X-XII, 22 (2004).
21. Bajgar J., Bartošová L., Fusek J., Jun D., Kuča K.: Arh. Hig. Rada Toksikol. 57, 391 (2006).
22. Ševelová L., Bajgar J., Saxena A., Doctor B. P.: Inhal. Toxicol. 16, S33, 2004.
23. Broomfield C. A., Lockridge O., Millard C. B., Lenz D. E.: Design and construction of butyrylcholinesterase mutants that have organophosphorus acid anhydride hydrolase activity. Mini-CB Medical Treatment Symposium, 26-30 May 1997, Hradec Kralove, Czech Republic. Abstracts, p. 13. Hradec Králové 1997.
24. Miller J. K., Lenz D. E.: J. Appl. Toxicol. 21, S23 (2001).
25. Bajgar J., Fusek J., Sevelova L., Kassa J.: Original transdermal prophylactic antidote against nerve agents - TRANSANT. CB Medical Treatment Symposium, 25-30 April 2004, Spiez, Switzerland. Technical Program p.14, Spiez 2004.
26. Kubova H., Herink J., Mares P.: Activ. Nerv. Sup. (Prague) 32, 211 (1990).
27. Galli A., Mazri A.: Toxicol. Appl. Pharmacol. 95, 388 (1988).
28. Stojiljkovic M. P., Maksimovic M., Bokonjic D., Kilibarda V., Tadic V., Boskovic B.: Adamantanes versus carbamates as prophylactic agents in soman-poisoned rats. In "Proceedings from the 6th CBW Protection Symposium, Stockholm, May 10-15 1998", pp. 197-202. Stockholm 1998.
29. Myhrer T., Enger S., Aas P.: Soman-induced seizures in rats: possible treatment and prophylaxis. In "Symposium Proceedings, NBC 2003", 15-18 June 2003, Jyvaskyla, Finland, pp. 136-137. Jyvaskyla 2003.
30. Anderson D. R., Harris L. W., Chang F. C. T., Baze W. B., Capacio B. R., Byers S. L., Lennox W. J.: Drug Chem. Toxicol. 20, 115 (1997).
31. Kassa J., Bajgar J.: Hum. Exp. Toxicol. 15, 383 (1996).
32. Tuovinen K., Kaliste-Korhonen E., Raushel F. M., Hanninen O.: Toxicology 134, 169 (1999).
33. Tuovinen K.: Comparison of pyridostigmine, physostigmine, heptylphysostigmine and phosphotriesterase treatments in sarin intoxication. In "Supplementum Proceedings from the 6th CBW Protection Symposium, Stockholm, May 10-15 1998", p. 254. Stockholm 1998.
34. Loke W. K., Chua E., Loo H. P., Tan S. H., Teo C.: Anticonvulsant effects of post-intoxication administered atropine-clonidine drug combination in soman-poisoned rats. In "Seventh International Symposium on Protection against CBWA. Stockholm, 15-19 June 2001". Abstracts p. 160. Stockholm 2001.
35. Meshulam Y., Cohen G., Chapman S., Alkalai D., Levy A.: J. Appl. Toxicol. 21, Suppl. 1, S75 (2001).